Stephen Chang PhD

Stephen Chang, PhD is Vice President for Research and Development at The New York Stem Cell Foundation. Prior to joining NYSCF, Dr. Chang served as Chief Scientific Officer of Stemgent and as CEO of Multicell Technologies. Dr. Chang is president of CURES, a coalition dedicated to ensuring the safety, research, and development of innovative lifesaving medications. Dr. Stephen Chang joined NYSCF in 2010 as the Vice President of Research and Development after serving as Chief Scientific Officer of Stemgent upon the company’s founding in 2008. He was previously the CEO of Multicell Technologies and continues as a director of this company. Prior to that, he was the CEO of Astral Immunotherapy which was acquired by Multicell Technologies in 2005. Previously, he was chief science officer (CSO) and vice president of Canji Inc. / Schering Plough Research Institute in San Diego from 1998 to 2004. He has also held senior management positions at Chiron and Viagene.